The goal will be to address the risk of malnutrition and the loss of lean muscle mass while on the GLP-1 therapy and to avoid or limit weight rebound after the therapy
The recent OCULUS RCT, involving 60 adults on a stable dose of GLP-1 and GLP-1/GIP RA and scheduled for endoscopy, 149 found that individuals who paused their therapy for one dose prior to their procedure ( n = 32) had a higher residual gastric content volume (RGV) that precluded adequate visualization during the endoscopy in 3.1% of cases, whereas participants who continued their GLP-1 and GLP-1/GIP RA therapy ( n = 28) had RGV that precluded adequate endoscopy in 25% of cases ( P = 0.0029)
Diabetes Care 1998;21:B1429
The mean changes from baseline to Week 26 for fasting serum glucose were -32 mg/dL and -38 mg/dL, and for body weight were -2.7 kg and -3.6 kg for BYDUREON and liraglutide, respectively
The more you learn about botanical medicine, the more you realize that nature has provided these incredible plants and substances that have so many different healing properties
This provides early warning of hypoglycemia patterns or developing insulin resistance